Noss M B, Panicucci R, McClelland R A, Rauth A M
Ontario Cancer Institute, University of Toronto, Canada.
Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):1015-9. doi: 10.1016/0360-3016(89)90906-1.
We tested 1-methyl-2-nitrosoimidazole (INO), the two electron reduction product of 1-methyl-2-nitroimidazole (INO2) for its in vitro cytotoxicity and glutathione (GSH) depleting capabilities. The half life of INO was shown to be dependent on cell concentration above 10(5) cells/ml, decreasing with increasing cell concentration up to 2 X 10(6) cells/ml. For a 10-fold decrease in cell concentration, from 10(6) to 10(5) cells/ml, the toxicity curve shifted 10-fold towards lower concentrations. At 10(6) cells/ml, INO depleted GSH, in the range of concentrations where toxicity was observed, down to a plateau of 15% of the control level at a concentration of 100 microM INO. Oxidized glutathione (GSSG) levels were not elevated significantly above control cultures at this concentration. INO2, 1000 microM, did not deplete GSH under similar exposure conditions while 2-hydroxylamino-1-methylimidazole (INHOH) depleted GSH minimally at this same concentration. The nitroso intermediate may play a central role in the toxicity and GSH depleting capabilities of 2-nitroimidazoles in mammalian cells.
我们测试了1-甲基-2-亚硝基咪唑(INO),即1-甲基-2-硝基咪唑(INO₂)的双电子还原产物的体外细胞毒性和谷胱甘肽(GSH)消耗能力。INO的半衰期显示取决于细胞浓度高于10⁵个细胞/毫升,随着细胞浓度增加至2×10⁶个细胞/毫升而降低。对于细胞浓度从10⁶降至10⁵个细胞/毫升的10倍降低,毒性曲线向较低浓度方向移动10倍。在10⁶个细胞/毫升时,在观察到毒性的浓度范围内,INO消耗GSH,在100微摩尔INO浓度下降至对照水平的15%的平稳期。在此浓度下,氧化型谷胱甘肽(GSSG)水平未显著高于对照培养物。1000微摩尔的INO₂在类似暴露条件下不消耗GSH,而2-羟基氨基-1-甲基咪唑(INHOH)在此相同浓度下最小程度地消耗GSH。亚硝基中间体可能在2-硝基咪唑类对哺乳动物细胞的毒性和GSH消耗能力中起核心作用。